# Turk İlaç 1 Ocak–30 Eylül 2026’da 577,3 milyon TL net zarar açıkladı - Bağlantı: https://www.borsatek.com/trilc-9-ayda-577-3-milyon-tl-net-zarar/ - Yayımlanma: 2026-10-30T18:12:23+03:00 - Yazar: Haber Merkezi Turk İlaç (TRILC), 1 Ocak–30 Eylül 2026 döneminde 577,3 milyon TL net zarar açıkladı. Şirketten KAP’a gönderilen bildirime göre, toplam varlıklar 8.537.450.203 TL oldu; önceki dönemde 8.558.301.345 TL seviyesindeydi. Toplam yükümlülükler 7.103.772.443 TL, ana ortaklığa ait özkaynaklar 1.433.677.760 TL seviyesinde gerçekleşti. Dönen varlıklar 5.316.298.341 TL’ye, nakit ve nakit benzerleri 5.879.538 TL’ye indi. Ticari alacaklar 3.620.014.095 TL’ye çıktı; ilişkili taraflardan alacaklar 1.587.551.263 TL oldu. Hasılat 3.630.931.084 TL olarak kaydedildi. Finansal Tablolar ![Finansal Durum Tablosu (Bilanço)](https://i3.wp.com/www.borsatek.com/app/uploads/ 2026/10/kap-fin-1689878-t01.png) ![Kar veya Zarar Tablosu](https://i1.wp.com/www.borsatek.com/app/uploads/2026/10/ kap-fin-1689878-t02.png) ![Nakit Akış Tablosu](https://i1.wp.com/www.borsatek.com/app/uploads/2026/10/kap- fin-1689878-t03.png) ![Kar veya Zarar Tablosu](https://i2.wp.com/www.borsatek.com/app/uploads/2026/10/ kap-fin-1689878-t04.png) 📎 Bildirim Ekleri [📄Türk İlaç_0926.pdfPDF](https://www.borsatek.com/kap-git/?u=aHR0cHM6Ly93d3cua2FwLm9yZy50ci90ci9hcGkvZmlsZS9kb3dubG9hZC80MDI4MzI4Y2ExN2U0ZjVmMDFhMThjZjk2ZDA4NjQ0Mw) Bildirim Eki Sayfaları ![Türk İlaç_0926.pdf — sayfa 1](https://i2.wp.com/www.borsatek.com/app/uploads/2026/ 10/kap-4028328ca17e4f5f01a18cf96d086443-p01.webp) ![Türk İlaç_0926.pdf — sayfa 2](https://i3.wp.com/www.borsatek.com/app/uploads/2026/ 10/kap-4028328ca17e4f5f01a18cf96d086443-p02.webp) ![Türk İlaç_0926.pdf — sayfa 3](https://i1.wp.com/www.borsatek.com/app/uploads/2026/ 10/kap-4028328ca17e4f5f01a18cf96d086443-p03.webp) ![Türk İlaç_0926.pdf — sayfa 4](https://i1.wp.com/www.borsatek.com/app/uploads/2026/ 10/kap-4028328ca17e4f5f01a18cf96d086443-p04.webp) ![Türk İlaç_0926.pdf — sayfa 5](https://i2.wp.com/www.borsatek.com/app/uploads/2026/ 10/kap-4028328ca17e4f5f01a18cf96d086443-p05.webp) ![Türk İlaç_0926.pdf — sayfa 6](https://i3.wp.com/www.borsatek.com/app/uploads/2026/ 10/kap-4028328ca17e4f5f01a18cf96d086443-p06.webp) ![Türk İlaç_0926.pdf — sayfa 7](https://i3.wp.com/www.borsatek.com/app/uploads/2026/ 10/kap-4028328ca17e4f5f01a18cf96d086443-p07.webp) ![Türk İlaç_0926.pdf — sayfa 8](https://i3.wp.com/www.borsatek.com/app/uploads/2026/ 10/kap-4028328ca17e4f5f01a18cf96d086443-p08.webp) ![Türk İlaç_0926.pdf — sayfa 9](https://i1.wp.com/www.borsatek.com/app/uploads/2026/ 10/kap-4028328ca17e4f5f01a18cf96d086443-p09.webp) ![Türk İlaç_0926.pdf — sayfa 10](https://i3.wp.com/www.borsatek.com/app/uploads/ 2026/10/kap-4028328ca17e4f5f01a18cf96d086443-p10.webp) ![Türk İlaç_0926.pdf — sayfa 11](https://i1.wp.com/www.borsatek.com/app/uploads/ 2026/10/kap-4028328ca17e4f5f01a18cf96d086443-p11.webp) ![Türk İlaç_0926.pdf — sayfa 12](https://i2.wp.com/www.borsatek.com/app/uploads/ 2026/10/kap-4028328ca17e4f5f01a18cf96d086443-p12.webp) ![Türk İlaç_0926.pdf — sayfa 13](https://i2.wp.com/www.borsatek.com/app/uploads/ 2026/10/kap-4028328ca17e4f5f01a18cf96d086443-p13.webp) ![Türk İlaç_0926.pdf — sayfa 14](https://i3.wp.com/www.borsatek.com/app/uploads/ 2026/10/kap-4028328ca17e4f5f01a18cf96d086443-p14.webp) ![Türk İlaç_0926.pdf — sayfa 15](https://i1.wp.com/www.borsatek.com/app/uploads/ 2026/10/kap-4028328ca17e4f5f01a18cf96d086443-p15.webp) ![Türk İlaç_0926.pdf — sayfa 16](https://i2.wp.com/www.borsatek.com/app/uploads/ 2026/10/kap-4028328ca17e4f5f01a18cf96d086443-p16.webp) ![Türk İlaç_0926.pdf — sayfa 17](https://i1.wp.com/www.borsatek.com/app/uploads/ 2026/10/kap-4028328ca17e4f5f01a18cf96d086443-p17.webp) ![Türk İlaç_0926.pdf — sayfa 18](https://i2.wp.com/www.borsatek.com/app/uploads/ 2026/10/kap-4028328ca17e4f5f01a18cf96d086443-p18.webp) ![Türk İlaç_0926.pdf — sayfa 19](https://i1.wp.com/www.borsatek.com/app/uploads/ 2026/10/kap-4028328ca17e4f5f01a18cf96d086443-p19.webp) ![Türk İlaç_0926.pdf — sayfa 20](https://i3.wp.com/www.borsatek.com/app/uploads/ 2026/10/kap-4028328ca17e4f5f01a18cf96d086443-p20.webp) ![Türk İlaç_0926.pdf — sayfa 21](https://i1.wp.com/www.borsatek.com/app/uploads/ 2026/10/kap-4028328ca17e4f5f01a18cf96d086443-p21.webp) ![Türk İlaç_0926.pdf — sayfa 22](https://i2.wp.com/www.borsatek.com/app/uploads/ 2026/10/kap-4028328ca17e4f5f01a18cf96d086443-p22.webp) ![Türk İlaç_0926.pdf — sayfa 23](https://i2.wp.com/www.borsatek.com/app/uploads/ 2026/10/kap-4028328ca17e4f5f01a18cf96d086443-p23.webp) ![Türk İlaç_0926.pdf — sayfa 24](https://i2.wp.com/www.borsatek.com/app/uploads/ 2026/10/kap-4028328ca17e4f5f01a18cf96d086443-p24.webp) ![Türk İlaç_0926.pdf — sayfa 25](https://i3.wp.com/www.borsatek.com/app/uploads/ 2026/10/kap-4028328ca17e4f5f01a18cf96d086443-p25.webp) ![Türk İlaç_0926.pdf — sayfa 26](https://i1.wp.com/www.borsatek.com/app/uploads/ 2026/10/kap-4028328ca17e4f5f01a18cf96d086443-p26.webp) ![Türk İlaç_0926.pdf — sayfa 27](https://i1.wp.com/www.borsatek.com/app/uploads/ 2026/10/kap-4028328ca17e4f5f01a18cf96d086443-p27.webp) ![Türk İlaç_0926.pdf — sayfa 28](https://i1.wp.com/www.borsatek.com/app/uploads/ 2026/10/kap-4028328ca17e4f5f01a18cf96d086443-p28.webp) ![Türk İlaç_0926.pdf — sayfa 29](https://i3.wp.com/www.borsatek.com/app/uploads/ 2026/10/kap-4028328ca17e4f5f01a18cf96d086443-p29.webp) ![Türk İlaç_0926.pdf — sayfa 30](https://i2.wp.com/www.borsatek.com/app/uploads/ 2026/10/kap-4028328ca17e4f5f01a18cf96d086443-p30.webp)